Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation | World Journal of Surgical Oncology | Full Text
Survivals of pancreatic neuroendocrine tumors with different grade by... | Download Scientific Diagram
Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors – a multi-institutional study - ScienceDirect
Prognosis and Long-Term Survival after Operation in Patients with
Death incidence and survival by European Neuroendocrine Tumor Society... | Download Scientific Diagram
Frontiers | Consideration of Age Is Necessary for Increasing the Accuracy of the AJCC TNM Staging System of Pancreatic Neuroendocrine Tumors
Sex-Based Clinicopathologic and Survival Differences Among Patients with Pancreatic Neuroendocrine Tumors | SpringerLink
An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan | Scientific Reports
Pancreatic neuroendocrine tumor - Wikipedia
Prognostic factors of long‑term outcome in surgically resectable pancreatic neuroendocrine tumors: A 12‑year experience from a single center
Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital - ScienceDirect
Making Sense of a Complex Disease: A Practical Approach to Managing Neuroendocrine Tumors | JCO Oncology Practice
Prognosis of Patients with Neuroendocrine Neoplasms of the Pancre
Incidence and survival of neuroendocrine neoplasia in England 1995–2018: A retrospective, population-based study - The Lancet Regional Health – Europe
Kaplan–Meier analyses of overall survival. (a) Overall survival in... | Download Scientific Diagram
Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67 | Annals of Surgical Oncology
Time-trend and recurrence analysis of pancreatic neuroendocrine tumors in: Endocrine Connections Volume 8 Issue 7 (2019)
Treatment of metastatic pancreatic neuroendocrine tumors: relevance of ENETS 2016 guidelines in: Endocrine-Related Cancer Volume 24 Issue 2 (2017)
Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study | Journal of Clinical Oncology
Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma | AJR
Cancers | Free Full-Text | Updated Principles of Surgical Management of Pancreatic Neuroendocrine Tumours (pNETs): What Every Surgeon Needs to Know
Effect of metastatic site on survival in patients with neuroendocrine neoplasms (NENs). An analysis of SEER data from 2010 to 2014 | BMC Endocrine Disorders | Full Text
Plasma Chromogranin A Levels Predict Survival and Tumor Response in Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors | Anticancer Research
Neuroendocrine Tumors - Cancer Therapy Advisor
Incidence and survival of neuroendocrine neoplasia in England 1995–2018: A retrospective, population-based study - The Lancet Regional Health – Europe
Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations
Pathophysiology and Treatment of Pancreatic Neuroendocrine Neoplasms (PNENS): New Developments - Endotext - NCBI Bookshelf
